Together we invest in enabling personalized medicine for all
PMV nv is a Flemish investment company. It offers financing solutions to companies that operate in Flanders and have a sound business plan and management team. It covers a company’s entire development cycle, from its earliest inception to its growth and internationalization. Besides corporate investments, PMV also invests in large infrastructure projects and real estate. It focuses on the sustainable economic development of Flanders, with demonstrable added value for both economy and society. PMV’s Flanders’ Care Invest fund aims at augmenting the quality of care in Flanders by innovating it. It provides equity to companies that develop and market innovative new products and services, and is part of the Flanders’ Care project, which constitutes an important element of the Flanders in Action Campaign.
Qbic is an inter-university early stage venture capital fund that invests in spin-offs of the universities of Ghent, Brussels and Antwerp and of their associated colleges and university hospitals. The Qbic Fund was established in May 2012 with an initial committed capital of 30,5 million EUR to support the creation of spin-off companies with both capital and hands-on support and coaching. The Qbic ARKIV Fund is a joint initiative with the ARKimedes II Fund.
Gimv is a European investment company with more than 30 years’ experience in private equity and venture capital. The company is listed on NYSE Euronext Brussels and currently manages around EUR 1.8 billion of investments (including investment partnerships) in 54 portfolio companies generating an overall turnover of more than EUR 6 billion and employing over 26,000 professionals. As a recognized leader in selected investment platforms, Gimv identifies entrepreneurial and innovative companies with high growth potential and guides and supports them in their transformation into market leaders. The four investment platforms are: Consumer 2020, Health & Care, Smart Industries en Sustainable Cities. Each of these platforms works with a skilled and dedicated team in Gimv’s home market (Benelux, France and Germany) and is backed by an extensive international network of experts.
VIB is a research institution dedicated to conduct frontline research in fields such as angiogenesis, immunology, oncology, neurobiology, infectious diseases, microbiology, plant sciences, protein chemistry, bioinformatics and system biology. VIB has worldwide collaborations with academia and industry and (co-)founded start-ups such as Devgen, CropDesign, Ablynx, Pronota, Actogenix and Solucel. VIB provides 12,000 m2 bioincubator space to local and international biotech companies. VIB is also actively involved in science communication.
University of Antwerp
UA, or University of Antwerp is characterized by its high standards in education, internationally competitive research and entrepreneurial approach. It was founded in 2003 after the merger of three university institutions previously known as RUCA, UFSIA and UIA. Their roots go back to 1852. The University of Antwerp has about 13,000 students, which makes it the third largest university in Flanders. 1,800 international students (exchange students not included) are registered at the UA. The University of Antwerp forms the backbone of the Antwerp University Association (AUHA) a strategic collaboration with four university colleges in the city of Antwerp.